Cellectis
CELLECTIS · public limited company with a board of directors (n.o.s.)
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 60 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
0
confidence 70 % · metrics-v1
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
4.9
confidence 67 % · cci-v1
11 active sensors·2 observations·0 historical changes·0 structured events·historical coverage 93 %·observed since 2026-09-13
Compare Cellectis with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies